Free Trial

Clark Estates Inc. NY Invests $1.85 Million in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Key Points

  • Clark Estates Inc. NY has acquired 27,138 shares of Maximus, Inc. (NYSE:MMS), valuing the investment at approximately $1.85 million, as disclosed to the SEC.
  • Several institutional investors have increased their holdings in Maximus, with Vanguard Group Inc. boosting its position by 3.2% in the last quarter.
  • Maximus recently reported quarterly earnings of $2.01 EPS, exceeding analysts' estimates, and announced a $0.30 quarterly dividend with an annualized yield of 1.67%.
  • Interested in Maximus? Here are five stocks we like better.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Clark Estates Inc. NY acquired a new position in Maximus, Inc. (NYSE:MMS - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 27,138 shares of the health services provider's stock, valued at approximately $1,851,000.

Other hedge funds also recently added to or reduced their stakes in the company. LRI Investments LLC lifted its position in shares of Maximus by 11.9% during the first quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock valued at $125,000 after buying an additional 195 shares during the last quarter. Vestcor Inc lifted its position in shares of Maximus by 2.3% during the first quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock valued at $674,000 after buying an additional 223 shares during the last quarter. Cetera Investment Advisers lifted its position in shares of Maximus by 5.8% during the first quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider's stock valued at $308,000 after buying an additional 247 shares during the last quarter. UMB Bank n.a. lifted its position in shares of Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after buying an additional 250 shares during the last quarter. Finally, Nisa Investment Advisors LLC lifted its position in shares of Maximus by 0.7% during the first quarter. Nisa Investment Advisors LLC now owns 39,936 shares of the health services provider's stock valued at $2,723,000 after buying an additional 290 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Check Out Our Latest Research Report on Maximus

Insider Activity at Maximus

In other news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the sale, the director owned 14,205 shares of the company's stock, valued at $1,028,157.90. This trade represents a 35.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is owned by insiders.

Maximus Stock Performance

NYSE:MMS traded down $0.51 during midday trading on Wednesday, hitting $71.25. The company's stock had a trading volume of 361,858 shares, compared to its average volume of 394,607. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The firm's 50 day moving average is $71.30 and its 200-day moving average is $70.61. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.84 and a quick ratio of 1.84. The firm has a market cap of $4.01 billion, a P/E ratio of 14.17 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a net margin of 5.56% and a return on equity of 23.37%. The company had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the prior year, the company earned $1.57 EPS. Maximus's quarterly revenue was up 1.0% on a year-over-year basis. Equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.68%. Maximus's dividend payout ratio (DPR) is presently 23.86%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday
ACT FAST! Congress is Dumping these 3 Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines